| 詳細情報 |  |
|---|---|
| 関連リンク |  |
| 探す |  |
論文 (26件)
- Mohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, Benjamin Ruf, Yuta Myojin, Kylynda C Bauer, Patrick Huang, Chi Ma, Marina Villamor-Payà, Francisco Rodriguez-Matos, et al. Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME. Immunity. 2025
- Yuta Myojin, Sepideh Babaei, Rajiv Trehan, Christoph Hoffman, Noemi Kedei, Benjamin Ruf, Mohamed-Reda Benmebarek, Kylynda C Bauer, Patrick Huang, Chi Ma, et al. Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab. Gut. 2025
- Shusuke Kumazaki, Hayato Hikita, Yuki Tahata, Ji Hyun Sung, Kenji Fukumoto, Yuta Myojin, Sadatsugu Sakane, Kazuhiro Murai, Yoichi Sasaki, Kumiko Shirai, et al. Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis. Alimentary pharmacology & therapeutics. 2024
- Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Tatsuya Sakamoto, Ryohei Narumi, Jun Adachi, Naruyasu Kakita, Yukinori Yamada, Hidenori Toyoda, Hirokazu Takahashi, et al. Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD. Hepatology communications. 2024. 8. 6
- Kylynda C Bauer, Rajiv Trehan, Benjamin Ruf, Yuta Myojin, Mohamed-Reda Benmebarek, Chi Ma, Matthias Seifert, Amran Nur, Jonathan Qi, Patrick Huang, et al. The Gut Microbiome Controls Liver Tumors via the Vagus Nerve. bioRxiv : the preprint server for biology. 2024
- Cecilia Monge, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, et al. Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine. 2024
- Kelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, et al. VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer. 2024. 12. 1
- Yuta Myojin, Justin D McCallen, Chi Ma, Kylynda C Bauer, Benjamin Ruf, Mohamed-Reda Benmebarek, Benjamin L Green, Simon Wabitsch, John C McVey, Claude Fu, et al. Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers. JHEP reports : innovation in hepatology. 2024. 6. 1. 100959-100959
- Benjamin L Green, Yuta Myojin, Chi Ma, Benjamin Ruf, Lichun Ma, Qianfei Zhang, Umberto Rosato, Jonathan Qi, Mahler Revsine, Simon Wabitsch, et al. Immunosuppressive CD29+ Treg accumulation in the liver in mice on checkpoint inhibitor therapy. Gut. 2023
- Benjamin Ruf, Matthias Bruhns, Sepideh Babaei, Noemi Kedei, Lichun Ma, Mahler Revsine, Mohamed-Reda Benmebarek, Chi Ma, Bernd Heinrich, Varun Subramanyam, et al. Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin. Cell. 2023. 186. 17. 3686-3705
- Cecilia Monge, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, et al. Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer. 2023. 11. 2
- Takayuki Matsumae, Takahiro Kodama, Yuki Tahata, Yuta Myojin, Akira Doi, Akira Nishio, Ryoko Yamada, Yasutoshi Nozaki, Masahide Oshita, Naoki Hiramatsu, et al. Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral. Cancers. 2023. 15. 2
- Katsuhiko Sato, Hayato Hikita, Minoru Shigekawa, Seiya Kato, Yoichi Sasaki, Kazuma Shinkai, Makoto Fukuoka, Shinnosuke Kudo, Yu Sato, Kenji Fukumoto, et al. PTX3 Is an Adipose Tissue-Related Serum Marker for Pancreatic Cancer Cachexia Predicting Subsequent Muscle Mass and Visceral Fat Loss. Cancer science. 2022. 113. 12. 4311-4326
- Takayuki Matsumae, Takahiro Kodama, Yuta Myojin, Kazuki Maesaka, Ryotaro Sakamori, Ayako Takuwa, Keiko Oku, Daisuke Motooka, Yoshiyuki Sawai, Masahide Oshita, et al. Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy. Cancers. 2022. 14. 14
- Yuta Myojin, Hayato Hikita, Yuki Tahata, Akira Doi, Seiya Kato, Yoichi Sasaki, Kumiko Shirai, Sadatsugu Sakane, Ryoko Yamada, Takahiro Kodama, et al. Letter: serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination-authors' reply. Alimentary pharmacology & therapeutics. 2022. 55. 8. 1061-1062
- Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori, Kazuki Maesaka, Takayuki Matsumae, Yoshiyuki Sawai, Yasuharu Imai, Kazuyoshi Ohkawa, Masanori Miyazaki, Satoshi Tanaka, et al. Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy. Cancers. 2022. 14. 4
- Bernd Heinrich, Benjamin Ruf, Varun Subramanyam, Yuta Myojin, Chunwei W Lai, Amanda J Craig, Jianyang Fu, Changqing Xie, Alexander Kroemer, Tim F Greten, et al. Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma. Frontiers in immunology. 2022. 13. 849958-849958
- Yuta Myojin, Hayato Hikita, Yuki Tahata, Akira Doi, Seiya Kato, Yoichi Sasaki, Kumiko Shirai, Sadatsugu Sakane, Ryoko Yamada, Takahiro Kodama, et al. Serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination. Alimentary pharmacology & therapeutics. 2021. 55. 4. 422-433
- Makiko Urabe, Hayato Hikita, Yoshinobu Saito, Shinnosuke Kudo, Kenji Fukumoto, Naoki Mizutani, Yuta Myojin, Akira Doi, Katsuhiko Sato, Sadatsugu Sakane, et al. Activation of p53 After Irradiation Impairs the Regenerative Capacity of the Mouse Liver. Hepatology communications. 2021. 6. 2. 411-422
- Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Yuta Myojin, Youichi Sasaki, Shinnosuke Kudo, Kenji Fukumoto, Naoki Mizutani, Yuki Tahata, Yuki Makino, et al. White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice. Cellular and molecular gastroenterology and hepatology. 2021. 12. 5. 1683-1699
前のページに戻る
